SCHEMBL2412684

SCHEMBL2412684

C1=CC(c2ccccc2)(c2ccc(N3CCCCC3)cc2)Oc2cc(N3CCOCC3)c3ccccc3c21

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.41
KDM4E B2RXH2 4/20 0.41
NPSR1 Q6W5P4 3/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
TSHR P16473 2/20 0.41
HPGD P15428 2/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
POLB P06746 1/20 0.41
GAA P10253 1/20 0.41
HSD17B10 Q99714 1/20 0.41
MAPT P10636 4/20 0.38
LMNA P02545 2/20 0.38
CYP3A4 P08684 1/20 0.38
THRB P10828 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
BLM P54132 1/20 0.38
NCF1 P14598 4/20 0.37
PRKDC P78527 4/20 0.35
PKM P14618 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29501170 1.00 ALDH1A1 (0.41) ALDH1A1KDM4ENPSR1SMN1; SMN2TSHR
SCHEMBL2599669 0.99 KDM4E (0.39) ALDH1A1KDM4ENPSR1SMN1; SMN2TSHR
SCHEMBL8506443 0.97 NPSR1 (0.40) ALDH1A1KDM4ENPSR1SMN1; SMN2TSHR
SCHEMBL29375632 0.96 KDM4E (0.40) ALDH1A1KDM4ENPSR1SMN1; SMN2TSHR
SCHEMBL1408640 0.96 KDM4E (0.40) ALDH1A1KDM4ENPSR1SMN1; SMN2TSHR
SCHEMBL12206758 0.92 ALDH1A1 (0.37) ALDH1A1KDM4ENPSR1SMN1; SMN2TSHR
SCHEMBL12205327 0.92 ALDH1A1 (0.37) ALDH1A1KDM4ENPSR1SMN1; SMN2TSHR
SCHEMBL21338487 0.92 ALDH1A1 (0.37) ALDH1A1KDM4ENPSR1SMN1; SMN2TSHR
SCHEMBL4784200 0.92 NCF1 (0.42) ALDH1A1KDM4ENPSR1SMN1; SMN2TSHR
SCHEMBL6169045 0.91 ALDH1A1 (0.38) ALDH1A1KDM4ENPSR1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 110 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1410786-B1 Cosmetic composition comprising at least two dyes whereof at least one is photochromic OREAL (FR) 2008-01-02 EP claimed
EP-1410784-B1 Cosmetic composition comprising an oil phase and a naphthopyran dye and method OREAL (FR) 2007-02-07 EP claimed
EP-1410785-B1 Make-up product, combining two compositions, comprising a photochromic dye and a goniochromatic agent, respectively OREAL (FR) 2007-01-03 EP claimed
US-20050276767-A1 Composition containing an oily phase and a naphthopyran dye, cosmetic treatment processes L'OREAL (FR) 2005-12-15 US claimed
US-20040228817-A1 Makeup combining at least one photochromic dye and at least one goniochromatic agent L'OREAL (FR) 2004-11-18 US claimed
US-20040228818-A1 Cosmetic composition combining at least two dyes including at least one photochromic dye L'OREAL (FR) 2004-11-18 US claimed
EP-1410784-A1 Cosmetic composition comprising an oil phase and a naphthopyran dye and method L'OREAL (FR) 2004-04-21 EP claimed
EP-0973761-B1 RED COLOURING HYPERCHROMIC 3H-NAPHTHO 2,1-b ]PYRANS JAMES ROBINSON LTD (GB) 2002-07-03 EP claimed
US-6294112-B1 Red coloring hyperchromic 3H-naphtho[2,1-B]pyrans JAMES ROBINSON LIMITED (GB) 2001-09-25 US claimed
EP-0973761-A1 RED COLOURING HYPERCHROMIC 3$i(H)-NAPHTHO 2,1-$i(b)]PYRANS JAMES ROBINSON LIMITED (GB) 2000-01-26 EP claimed
WO-1998045281-A1 RED COLOURING HYPERCHROMIC 3H-NAPHTHO[2,1-b]PYRANS JAMES ROBINSON LIMITED (GB) 1998-10-15 WO claimed
US-20250345255-A1 COMPOSITIONS FOR IMPROVING NAIL HEALTH L'ORÉAL (FR) 2025-11-13 US disclosed
US-12232593-B2 Method for shaping an applicator for applying a cosmetic composition L'OREAL (FR) 2025-02-25 US disclosed
EP-3989772-B1 METHOD FOR SHAPING AN APPLICATOR FOR APPLYING A COSMETIC COMPOSITION OREAL (FR) 2024-04-10 EP disclosed
EP-4051053-B1 SYSTEM FOR TAKING UP AND APPLYING A COSMETIC COMPOSITION OREAL (FR) 2023-11-08 EP disclosed
EP-1162482-A2 Synthetic resin laminate having both polarization characteristic and photochromism characteristic MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2001-12-12 EP disclosed
WO-2001092926-A1 PHOTOCHROMIC PLASTIC OBJECT WITH PERMANENTLY INCREASED CONTRAST OPTISCHE WERKE G. RODENSTOCK (DE) 2001-12-06 WO disclosed
US-6306316-B1 Photochromic plastic object OPTISCHE WERKE G. RODENSTOCK (DE) 2001-10-23 US disclosed
US-6294112-B1 Red coloring hyperchromic 3H-naphtho[2,1-B]pyrans JAMES ROBINSON LIMITED (GB) 2001-09-25 US disclosed
EP-1099743-A1 Photochromic plastic article Optische Werke G. Rodenstock (DE) 2001-05-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040228817-A1 Makeup combining at least one photochromic dye and at least one goniochromatic agent GYPA, TYR, GLA ALDH1A1 176/4885KDM4E 4265/4885NPSR1 4195/4885
US-20050276767-A1 Composition containing an oily phase and a naphthopyran dye, cosmetic treatment processes CUTA, TYR, TPSD1 ALDH1A1 652/4885KDM4E 4667/4885NPSR1 1324/4885
US-20040228818-A1 Cosmetic composition combining at least two dyes including at least one photochromic dye CUTA, TYR, LAGE3 ALDH1A1 420/4885KDM4E 3484/4885NPSR1 4298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.